VENDRELY , V.

Last name: VENDRELY

First name: V.

February 2022 (v1)

Journal article

Metadata-only

Rectal cancer radiotherapy

Vendrely, V. Rivin del Campo, E. Modesto, A.

We present the updated recommendations of the French society of oncological radiotherapy for rectal cancer radiotherapy. The standard treatment for locally advanced rectal cancer consists in chemoradiotherapy followed by radical surgery with total mesorectal resection and adjuvant chemotherapy according to nodal status. Although this strategy...

Uploaded on: February 22, 2023
April 2018 (v1)

Journal article

Metadata-only

OC-0284: First results of the French cohort ANABASE : treatment and outcome in non-metastatic anal cancer

Vendrely, V. Lemanski, C. Francois, E.

International audience

Uploaded on: December 4, 2022
May 12, 2023 (v1)

Conference paper

Metadata-only

Capecitabine or 5-fluorouracil infusion with radiotherapy of anal cancers in the FFCD-Anabase cohort

Delhiat, A. Lemanski, C. Le-Malicot, K.

International audience

Uploaded on: January 13, 2024
October 1, 2017 (v1)

Journal article

Metadata-only

Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer

Azria, D. Doyen, J. Jarlier, M.

BackgroundOutcome of intermediate risk rectal cancer may be improved by the addition of oxaliplatin during 5-fluoruracil concomitant neoadjuvant chemoradiotherapy. The purpose of this study is to analyze the main clinical results of the ACCORD12 trial (NCT00227747) in rectal cancer after 5 years of follow-up.Patients and methodsInclusion...

Uploaded on: March 26, 2023

VENDRELY , V.

Recent uploads